Your browser doesn't support javascript.
loading
"SafetyNet": Evaluation of a Recovery Coach and Paramedic Intervention Following Naloxone Resuscitation From an Opioid Overdose.
Joseph, Daniel; Brokowski, Carolyn; D'Onofrio, Gail; Bogucki, Sandy; McGovern, Joanne; Allen, Rebecca; Dziura, James; Cone, David C; Pantalon, Michael V.
Afiliação
  • Joseph D; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Brokowski C; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
  • D'Onofrio G; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Bogucki S; Department of Biomedical Engineering, School of Mechanical, Aerospace, and Manufacturing Engineering, University of Connecticut, Storrs, CT, USA.
  • McGovern J; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Allen R; Yale School of Public Health, New Haven, CT, USA.
  • Dziura J; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Cone DC; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Pantalon MV; Yale School of Public Health, New Haven, CT, USA.
Subst Use Addctn J ; : 29767342241266412, 2024 Aug 22.
Article em En | MEDLINE | ID: mdl-39171791
ABSTRACT

OBJECTIVE:

Emergency department (ED)-initiated buprenorphine has proven efficacy, but many patients are reluctant to begin this treatment. This study evaluated SafetyNet, a program using a 2-person, recovery coach and paramedic (RCP) intervention postoverdose to reduce subsequent opioid overdose, engage patients in medications for opioid use disorder (MOUD), and reduce illicit drug use.

METHODS:

We conducted a prospective nonrandomized study in individuals who experienced opioid overdoses, received naloxone, but subsequently declined buprenorphine initiation in the ED. Each participant was followed by an RCP team that performed a brief negotiation interview (BNI) to motivate engagement in treatment, peer-recovery coaching to encourage recovery-related activities, and health education around medical concerns by trained paramedics. Participants were followed-up at 30 and 180 days. The primary hypothesized outcome was reduction in overdose events; the secondary hypothesized outcomes were engagement in MOUD and reduction in opioid positive urine tests.

RESULTS:

Eighty-one patients were enrolled and received BNIs; 45 (56%; 95% CI 44-67) had at least 1 follow-up encounter. Twenty participants (25%; 95% CI 16-36) had at least 1 overdose during follow-up. Fifty-five participants (68%; 95% CI 57-78) were confirmed to have engaged in some form of medication treatment. Differences in subsequent overdose events (P = .95), engagement in MOUD (P = .49), and rates of opioid-positive urine toxicology rates within 30 days (P = .44) and between 31 and 180 days (P = .46) were not significantly different when comparing those who did and did not follow-up.

CONCLUSION:

There were no differences in rates of subsequent overdose, MOUD engagement, or positive urine toxicology screens in our intervention. However, 68% of participants engaged in outpatient MOUD, a treatment associated with fewer overdose events, particularly fatal ones. Substantial limitations occurred due to the COVID pandemic, and sample size estimates were not met. Further research is needed to investigate potential benefits of the SafetyNet program.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article